Key financial indicators
Overview of key financial indicators in 1-9 2024
Sales (in EURm) | 1-9 2024 | 1-9 2023 | % change |
---|---|---|---|
Total revenues of Podravka Group | 573.7 | 527.0 | 8.9% |
Sales revenues of Podravka Group | 569.3 | 525.1 | 8.4% |
Sales revenues of Food | 438.9 | 406.9 | 7.9% |
Sales revenues of Pharma | 130.4 | 118.2 | 10.3% |
Podravka Group's profitability (in EURm) | 1-9 2024 | 1-9 2023 | % change |
Group's gross profit | 221.3 | 183.4 | 20.6% |
Group's gross profit margin | 38.9% | 34.9% | +394 bb |
Group's EBITDA | 98.2 | 72.5 | 35.5% |
Group's EBITDA margin | 17.2% | 13.8% | +344 bb |
Group's EBIT | 72.8 | 48.6 | 49.7% |
Group's EBIT margin | 12.8% | 9.3% | +352 bb |
Group's net profit after MI | 60.2 | 58.3 | 3.1% |
Group's net profit margin after MI | 10.6% | 11.1% | -54 bb |
Podravka Group's balance sheet (in EURm) | 9/30/2024 | 12/31/2023 | % change |
Total assets | 809.7 | 778.1 | 4.1% |
Shareholders' equity | 599.2 | 564.4 | 6.2% |
Minority interests | 11.0 | 10.6 | 2.9% |
Cash and cash equivalents | 21.2 | 42.5 | -50.2% |
Financial debt | 58.5 | 57.4 | 1.9% |
Net debt | 37.4 | 14.9 | 150.6% |
Podravka Group's cash flow (in EURm) | 1-9 2024 | 1-9 2023 | % change |
Net cash flow from operating activities | 52.2 | 73.6 | -29.1% |
Capital expenditures | (58.1) | (46.9) | 23.7% |
Depreciation and amortization | 25.3 | 23.8 | 5.9% |
Free cash flow | (5.9) | 26.7 | -121.9% |
Podravka Group's ratios and indicators | 9/30/2024 | 12/31/2023 | % change |
Employee number at the end of period (in units) | 6,345 | 6,163 | 3.0% |
P&L interest expense (in EURm) | 0.85 | 0.68 | 23.9% |
Sales revenues / Number of employees (in EUR000) | 119.5 | 115.8 | 3.1% |
Net profit after MI / Sales revenues (in EUR000) | 10.7 | 10.8 | -0.2% |
Return on average assets | 6.2% | 6.4% | -14 bb |
Return on average capital | 8.4% | 8.8% | -40 bb |
Return on average invested capital | 11.0% | 8.3% | +274 bb |
Total shareholders' equity / Total assets | 75.4% | 73.9% | -147 bb |
EBIT / P&L interest expense | 98.3 | 87.3 | 12.6% |
Net debt / EBITDA | 0.3 | 0.2 | 97.1% |
Sales (in EURm) | 1-6 2024 | 1-6 2023 | % change |
---|---|---|---|
Total revenues of Podravka Group | 381.5 | 347.4 | 9.8% |
Sales revenues of Podravka Group | 380.4 | 346.3 | 9.9% |
Sales revenues of Food | 290.5 | 265.2 | 9.6% |
Sales revenues of Pharma | 89.8 | 81.0 | 10.8% |
Podravka Group's profitability (in EURm) | 1-6 2024 | 1-6 2023 | % change |
Group's gross profit | 148.9 | 122.2 | 21.8% |
Group's gross profit margin | 39.1% | 35.3% | +384 bb |
Group's EBITDA | 65.8 | 48.3 | 36.2% |
Group's EBITDA margin | 17.3% | 14.0% | +334 bb |
Group's EBIT | 49.1 | 32.4 | 51.4% |
Group's EBIT margin | 12.9% | 9.4% | +354 bb |
Group's net profit after MI | 40.2 | 45.2 | -11.0% |
Group's net profit margin after MI | 10.6% | 13.1% | -247 bb |
Podravka Group's balance sheet (in EURm) | 6/30/2024 | 12/31/2023 | % change |
Total assets | 818.1 | 778.1 | 5.1% |
Shareholders' equity | 579.7 | 564.4 | 2.7% |
Minority interests | 10.7 | 10.6 | 0.1% |
Cash and cash equivalents | 49.1 | 42.5 | 15.4% |
Financial debt | 59.9 | 57.4 | 4.3% |
Net debt | 10.8 | 14.9 | -27.3% |
Podravka Group's cash flow (in EURm) | 1-6 2024 | 1-6 2023 | % change |
Net cash flow from operating activities | 45.3 | 45.1 | 0.5% |
Capital expenditures | (39.8) | (28.7) | 38.8% |
Depreciation and amortization | 16.7 | 15.9 | 5.2% |
Free cash flow | 5.6 | 16.5 | -66.2% |
Podravka Group's ratios and indicators | 6/30/2024 | 12/31/2023 | % change |
Employee number at the end of period (in units) | 6,171 | 6,163 | 0.1% |
P&L interest expense (in EURm) | 0.75 | 0.68 | 10.1% |
Sales revenues / Number of employees (in EUR000) | 121.2 | 115.8 | 4.6% |
Net profit after MI / Sales revenues (in EUR000) | 10.0 | 10.8 | -7.6% |
Return on average assets | 6.2% | 6.4% | -21 bb |
Return on average capital | 8.5% | 8.8% | -31 bb |
Return on average invested capital | 10.5% | 8.3% | +216 bb |
Total shareholders' equity / Total assets | 72.2% | 73.9% | +173 bb |
EBIT / P&L interest expense | 100.8 | 87.3 | 15.5% |
Net debt / EBITDA | 0.1 | 0.2 | -38.7% |
Sales (in EURm) | 1-3 2024 | 1-3 2023 | % change |
---|---|---|---|
Total revenues of Podravka Group | 192.2 | 176.4 | 9.0% |
Sales revenues of Podravka Group | 191.8 | 175.9 | 9.1% |
Sales revenues of Food | 146.5 | 131.7 | 11.3% |
Sales revenues of Pharma | 45.3 | 44.2 | 2.5% |
Podravka Group's profitability (in EURm) | 1-3 2024 | 1-3 2023 | % change |
Group's gross profit | 76.6 | 62.5 | 22.5% |
Group's gross profit margin | 39.9% | 35.6% | +437 bb |
Group's EBITDA | 37.9 | 27.3 | 38.8% |
Group's EBITDA margin | 19.7% | 15.5% | +423 bb |
Group's EBIT | 29.5 | 19.4 | 51.9% |
Group's EBIT margin | 15.4% | 11.0% | +434 bb |
Group's net profit after MI | 23.5 | 15.7 | 49.7% |
Group's net profit margin after MI | 12.2% | 8.9% | +332 bb |
Podravka Group's balance sheet (in EURm) | 3/31/2024 | 12/31/2023 | % change |
Total assets | 810.7 | 778.1 | 4.2% |
Shareholders' equity | 586.2 | 564.4 | 3.9% |
Minority interests | 10.3 | 10.6 | -3.1% |
Cash and cash equivalents | 54.0 | 42.5 | 27.0% |
Financial debt | 61.9 | 57.4 | 7.8% |
Net debt | 7.9 | 14.9 | -46.8% |
Podravka Group's cash flow (in EURm) | 1-3 2024 | 1-3 2023 | % change |
Net cash flow from operating activities | 26.2 | 30.9 | -15.3% |
Capital expenditures | (19.1) | (11.8) | 62.3% |
Depreciation and amortization | 8.4 | 7.9 | 6.2% |
Free cash flow | 7.1 | 19.2 | -63.0% |
Podravka Group's ratios and indicators | 3/31/2024 | 12/31/2023 | % change |
Employee number at the end of period (in units) | 6,171 | 6,163 | 0.1% |
P&L interest expense (in EURm) | 0.70 | 0.68 | 2.6% |
Sales revenues / Number of employees (in EUR000) | 118.3 | 115.8 | 2.1% |
Net profit after MI / Sales revenues (in EUR000) | 12.0 | 10.8 | 11.6% |
Return on average assets | 6.2% | 6.4% | -23 bb |
Return on average capital | 8.4% | 8.8% | -41 bb |
Return on average invested capital | 9.6% | 8.3% | +127 bb |
Total shareholders' equity / Total assets | 73.6% | 73.9% | +32 bb |
EBIT / P&L interest expense | 99.2 | 87.3 | 13.7% |
Net debt / EBITDA | 0.1 | 0.2 | -52.8% |
Sales (in EURm) | 1-12 2023 | 1-12 2022 | % change |
---|---|---|---|
Total revenues of Podravka Group | 717.0 | 684.2 | 4.8% |
Sales revenues of Podravka Group | 713.8 | 667.2 | 7.0% |
Sales revenues of Food | 553.6 | 522.2 | 6.0% |
Sales revenues of Pharma | 160.2 | 145.0 | 10.5% |
Podravka Group's profitability (in EURm) | 1-12 2023 | 1-12 2022 | % change |
Group's gross profit | 248.7 | 236.7 | 5.1% |
Group's gross profit margin | 34.8% | 35.5% | -64 bb |
Group's EBITDA | 91.9 | 93.9 | -2.0% |
Group's EBITDA margin | 12.9% | 14.1% | -119 bb |
Group's EBIT | 59.3 | 62.5 | -5.2% |
Group's EBIT margin | 8.3% | 9.4% | -107 bb |
Group's net profit after MI | 66.4 | 49.1 | 35.3% |
Group's net profit margin after MI | 9.3% | 7.4% | +194 bb |
Podravka Group's balance sheet (in EURm) | 12/31/2023 | 12/31/2022 | % change |
Total assets | 778.1 | 736.2 | 5.7% |
Shareholders' equity | 564.4 | 519.2 | 8.7% |
Minority interests | 10.6 | 9.4 | 12.9% |
Cash and cash equivalents | 42.5 | 21.9 | 94.1% |
Financial debt | 57.4 | 84.0 | -31.6% |
Net debt | 14.9 | 62.1 | -76.0% |
Podravka Group's cash flow (in EURm) | 1-12 2023 | 1-12 2022 | % change |
Net cash flow from operating activities | 115.4 | 75.0 | 53.8% |
Capital expenditures | (73.8) | (52.7) | 40.1% |
Depreciation and amortization | 31.8 | 30.4 | 4.8% |
Free cash flow | 41.6 | 22.4 | 86.0% |
Podravka Group's ratios and indicators | 12/31/2023 | 12/31/2022 | % change |
Employee number at the end of period (in units) | 6,163 | 6,299 | -2.2% |
P&L interest expense (in EURm) | 0.68 | 0.72 | -5.3% |
Sales revenues / Number of employees (in EUR000) | 115.8 | 105.9 | 9.4% |
Net profit after MI / Sales revenues (in EUR000) | 10.8 | 7.8 | 38.3% |
Return on average assets | 6.4% | 6.1% | +29 bb |
Return on average capital | 8.8% | 8.3% | +46 bb |
Return on average invested capital | 8.3% | 7.6% | +69 bb |
Total shareholders' equity / Total assets | 73.9% | 71.8% | -210 bb |
EBIT / P&L interest expense | 87.3 | 73.3 | 19.1% |
Net debt / EBITDA | 0.2 | 0.7 | -78.2% |
Sales (in EURm) | 1-9 2023 | 1-9 2022 | % change |
---|---|---|---|
Total revenues of Podravka Group | 527.0 | 496.6 | 6.1% |
Sales revenues of Podravka Group | 525.1 | 492.7 | 6.6% |
Sales revenues of Food | 406.9 | 388.3 | 4.8% |
Sales revenues of Pharma | 118.2 | 104.4 | 13.3% |
Podravka Group's profitability (in EURm) | 1-9 2023 | 1-9 2022 | % change |
Group's gross profit | 183.4 | 175.4 | 4.6% |
Group's gross profit margin | 34.9% | 35.6% | -67 bb |
Group's EBITDA | 72.5 | 69.0 | 5.0% |
Group's EBITDA margin | 13.8% | 14.0% | -21 bb |
Group's EBIT | 48.6 | 45.8 | 6.2% |
Group's EBIT margin | 9.3% | 9.3% | -3 bb |
Group's net profit after MI | 58.3 | 35.7 | 63.4% |
Group's net profit margin after MI | 11.1% | 7.2% | +386 bb |
Podravka Group's balance sheet (in EURm) | 30.9.2023 | 31.12.2022 | % change |
Total assets | 751.9 | 736.2 | 2.1% |
Shareholders' equity | 555.9 | 519.2 | 7.1% |
Minority interests | 10.3 | 9.4 | 9.3% |
Cash and cash equivalents | 28.5 | 21.9 | 30.0% |
Financial debt | 55.0 | 84.0 | -34.5% |
Net debt | 26.5 | 62.1 | -57.3% |
Podravka Group's cash flow (in EURm) | 1-9 2023 | 1-9 2022 | % change |
Net cash flow from operating activities | 73.6 | 69.0 | 6.8% |
Capital expenditures | (46.9) | (38.9) | 20.7% |
Depreciation and amortization | 23.8 | 22.7 | 5.1% |
Free cash flow | 26.7 | 30.1 | -11.2% |
Podravka Group's ratios and indicators | 30.9.2023 | 31.12.2022 | % change |
Employee number at the end of period (in units) | 6,198 | 6,299 | -1.6% |
P&L interest expense (in EURm) | 0.71 | 0.72 | -2.0% |
Sales revenues / Number of employees (in EUR000) | 112.9 | 105.9 | 6.6% |
Net profit after MI / Sales revenues (in EUR000) | 11.6 | 7.8 | 48.5% |
Return on average assets | 6.0% | 6.0% | +9 bb |
Return on average capital | 8.2% | 8.1% | +11 bb |
Return on average invested capital | 7.8% | 7.7% | +10 bb |
Total shareholders' equity / Total assets | 75.3% | 71.8% | -351 bb |
EBIT / P&L interest expense | 79.7 | 73.3 | 8.8% |
Net debt / EBITDA | 0.3 | 0.7 | -59.5% |
Sales (in EURm) | 1-6 2023 | 1-6 2022 | % change |
---|---|---|---|
Total revenues of Podravka Group | 347.4 | 324.4 | 7.1% |
Sales revenues of Podravka Group | 346.3 | 320.7 | 8.0% |
Sales revenues of Food | 265.2 | 254.0 | 4.4% |
Sales revenues of Pharma | 81.0 | 66.7 | 21.6% |
Podravka Group's profitability (in EURm) | 1-6 2023 | 1-6 2022 | % change |
Group's gross profit | 122.2 | 116.9 | 4.5% |
Group's gross profit margin | 35.3% | 36.5% | -117 bp |
Group's EBITDA | 48.3 | 48.5 | -0.3% |
Group's EBITDA margin | 14.0% | 15.1% | -116 bp |
Group's EBIT | 32.4 | 33.5 | -3.2% |
Group's EBIT margin | 9.4% | 10.5% | -108 bp |
Group's net profit after MI | 45.2 | 26.3 | 71.8% |
Group's net profit margin after MI | 13.1% | 8.2% | +485 bp |
Podravka Group's balance sheet (in EURm) | 30.6.2023 | 31.12.2022 | % change |
Total assets | 767.0 | 736.2 | 4.2% |
Shareholders' equity | 543.8 | 519.2 | 4.7% |
Minority interests | 10.0 | 9.4 | 6.6% |
Cash and cash equivalents | 50.7 | 21.9 | 131.4% |
Financial debt | 70.6 | 84.0 | -16.0% |
Net debt | 19.9 | 62.1 | -68.0% |
Podravka Group's cash flow (in EURm) | 1-6 2023 | 1-6 2022 | % change |
Net cash flow from operating activities | 45.1 | 66.8 | -32.4% |
Capital expenditures | (28.7) | (27.0) | 5.9% |
Depreciation and amortization | 15.9 | 15.0 | 6.2% |
Free cash flow | 16.5 | 39.7 | -58.6% |
Podravka Group's ratios and indicators | 30.6.2023 | 31.12.2022 | % change |
Employee number at the end of period (in units) | 6,267 | 6,299 | -0.5% |
P&L interest expense (in EURm) | 0.66 | 0.72 | -9.1% |
Sales revenues / Number of employees (in EUR000) | 110.5 | 105.9 | 4.4% |
Net profit after MI / Sales revenues (in EUR000) | 10.8 | 7.8 | 39.2% |
Return on average assets | 5.5% | 6.0% | -44 bp |
Return on average capital | 7.6% | 8.1% | -46 bp |
Return on average invested capital | 7.4% | 7.9% | -43 bp |
Total shareholders' equity / Total assets | 72.2% | 71.8% | -42 bp |
EBIT / P&L interest expense | 80.4 | 73.3 | 9.8% |
Net debt / EBITDA | 0.2 | 0.7 | -68.3% |
Sales (in EURm) | 1-3 2023 | 1-3 2022 | % change |
---|---|---|---|
Total revenues of Podravka Group | 176.4 | 156.3 | 12.9% |
Sales revenues of Podravka Group | 175.9 | 155.6 | 13.0% |
Sales revenues of Food | 131.7 | 124.4 | 5.9% |
Sales revenues of Pharma | 44.2 | 31.3 | 41.2% |
Podravka Group's profitability (in EURm) | 1-3 2023 | 1-3 2022 | % change |
Group's gross profit | 62.5 | 57.8 | 8.2% |
Group's gross profit margin | 35.6% | 37.1% | -158 bp |
Group's EBITDA | 27.3 | 22.6 | 20.7% |
Group's EBITDA margin | 15.5% | 14.5% | +99 bp |
Group's EBIT | 19.4 | 15.3 | 27.1% |
Group's EBIT margin | 11.0% | 9.8% | +122 bp |
Group's net profit after MI | 15.7 | 11.8 | 32.9% |
Group's net profit margin after MI | 8.9% | 7.6% | +133 bp |
Podravka Group's balance sheet (in EURm) | 31.3.2023 | 31.12.2022 | % change |
Total assets | 765.2 | 736.2 | 3.9% |
Shareholders' equity | 533.7 | 519.2 | 2.8% |
Minority interests | 9.8 | 9.4 | 3.6% |
Cash and cash equivalents | 41.4 | 21.9 | 88.9% |
Financial debt | 87.1 | 84.0 | 3.6% |
Net debt | 45.7 | 62.1 | -26.5% |
Podravka Group's cash flow (in EURm) | 1-3 2023 | 1-3 2022 | % change |
Net cash flow from operating activities | 30.9 | 42.2 | -26.6% |
Capital expenditures | (11.8) | (8.4) | 39.9% |
Depreciation and amortization | 7.9 | 7.3 | 7.4% |
Free cash flow | 19.2 | 33.7 | -43.2% |
Podravka Group's ratios and indicators | 31.3.2023 | 31.12.2022 | % change |
Employee number at the end of period (in units) | 6,272 | 6,299 | -0.4% |
P&L interest expense (in EURm) | 0.7 | 0.7 | -2.1% |
Sales revenues / Number of employees (in EUR000) | 109.6 | 105.9 | 3.5% |
Net profit after MI / Sales revenues (in EUR000) | 8.4 | 7.8 | 8.4% |
Return on average assets | 6.0% | 6.0% | +9 bp |
Return on average capital | 8.5% | 8.1% | +35 bp |
Return on average invested capital | 8.0% | 7.8% | +15 bp |
Total shareholders' equity / Total assets | 71.0% | 71.8% | -77 bp |
EBIT / P&L interest expense | 81.0 | 73.3 | 10.5% |
Net debt / EBITDA | 0.5 | 0.7 | -30.6% |
Sales (in HRKm) | 2022 | 2021 | % change |
---|---|---|---|
Total revenues of Podravka Group | 5,154.9 | 4,666.5 | 10.5% |
Sales revenues of Podravka Group | 5,026.8 | 4,631.5 | 8.5% |
Sales revenues of Food | 3,934.2 | 3,601.3 | 9.2% |
Sales revenues of Pharma | 1,092.6 | 1,030.3 | 6.0% |
Podravka Group's profitability (in HRKm) | 2022 | 2021 | % change |
Group's gross profit | 1,783.6 | 1,678.1 | 6.3% |
Group's gross profit margin | 35.5% | 36.2% | -75 bp |
Group's EBITDA | 707.2 | 592.0 | 19.5% |
Group's EBITDA margin | 14.1% | 12.8% | +129 bp |
Group's EBIT | 471.1 | 365.3 | 29.0% |
Group's EBIT margin | 9.4% | 7.9% | +148 bp |
Group's net profit after MI | 369.6 | 309.2 | 19.5% |
Group's net profit margin after MI | 7.4% | 6.7% | +68 bp |
Podravka Group's balance sheet (in HRKm) | 31.12.2022 | 31.12.2021 | % change |
Total assets | 5,547.1 | 4,909.0 | 13.0% |
Shareholders' equity | 3,911.8 | 3,631.0 | 7.7% |
Minority interests | 71.0 | 63.3 | 12.2% |
Cash and cash equivalents | 165.1 | 33.3 | 395.7% |
Financial debt | 633.2 | 493.8 | 28.2% |
Net debt | 468.1 | 460.5 | 1.6% |
Podravka Group's cash flow (in HRKm) | 2022 | 2021 | % change |
Net cash flow from operating activities | 565.4 | 517.1 | 9.4% |
Capital expenditures | (396.8) | (170.3) | 133.0% |
Depreciation and amortization | 228.7 | 218.2 | 4.8% |
Free cash flow | 168.6 | 346.8 | -51.4% |
Podravka Group's ratios and indicators | 12/31/2022 | 12/31/2021 | % change |
Employee number at the end of period (in units) | 6,299 | 6,557 | -3.9% |
P&L interest expense (in HRKm) | 5.4 | 6.8 | -20.9% |
Sales revenues / Number of employees (in HRK000) | 798.0 | 706.3 | 13.0% |
Net profit after MI / Sales revenues (in HRK000) | 58.7 | 47.2 | 24.4% |
Return on average assets | 6.1% | 6.3% | -25 bp |
Return on average capital | 8.3% | 8.8% | -48 bp |
Return on average invested capital | 7.6% | 7.7% | -8 bp |
Total shareholders' equity / Total assets | 71.8% | 75.3% | -346 bp |
EBIT / P&L interest expense | 73.3 | 56.9 | 28.8% |
Net debt / EBITDA | 0.7 | 0.8 | -1.6% |
Sales (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
---|---|---|---|
Total revenues of Podravka Group | 3,741.4 | 3,410.4 | 9.7% |
Sales revenues of Podravka Group | 3,712.6 | 3,383.5 | 9.7% |
Sales revenues of Food | 2,926.0 | 2,634.0 | 11.1% |
Sales revenues of Pharma | 786.6 | 749.5 | 5.0% |
Podravka Group's profitability (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
Group's gross profit | 1,321.7 | 1,248.9 | 5.8% |
Group's gross profit margin | 35.6% | 36.9% | -131 bp |
Group's EBITDA | 519.9 | 491.7 | 5.7% |
Group's EBITDA margin | 14.0% | 14.5% | -53 bp |
Group's EBIT | 344.8 | 328.4 | 5.0% |
Group's EBIT margin | 9.3% | 9.7% | -42 bp |
Group's net profit after MI | 269.1 | 259.3 | 3.8% |
Group's net profit margin after MI | 7.2% | 7.7% | -41 bp |
Podravka Group's balance sheet (in HRKm) | 30.9.2022 | 31.12.2021 | % change |
Total assets | 5,411.8 | 4,909.0 | 10.2% |
Shareholders' equity | 3,798.7 | 3,631.0 | 4.6% |
Minority interests | 69.2 | 63.3 | 9.4% |
Cash and cash equivalents | 209.5 | 33.3 | 528.9% |
Financial debt | 536.3 | 493.8 | 8.6% |
Net debt | 326.9 | 460.5 | -29.0% |
Podravka Group's cash flow (in HRKm) | 1-9 2022 | 1-9 2021 | % change |
Net cash flow from operating activities | 519.5 | 453.4 | 14.6% |
Capital expenditures | (292.8) | (100.3) | 191.9% |
Depreciation and amortization | 170.9 | 163.3 | 4.7% |
Free cash flow | 226.7 | 353.1 | -35.8% |
Podravka Group's ratios and indicators | 30.9.2022 | 31.12.2021 | % change |
Employee number at the end of period (in units) | 6,406 | 6,557 | -2.3% |
P&L interest expense (in HRKm) | 5.6 | 6.8 | -20.9% |
Sales revenues / Number of employees (in HRK000) | 774.4 | 706.3 | 9.6% |
Net profit after MI / Sales revenues (in HRK000) | 49.8 | 47.2 | 5.6% |
Return on average assets | 6.2% | 6.3% | -13 bp |
Return on average capital | 8.5% | 8.8% | -29 bp |
Return on average invested capital | 8.0% | 7.7% | +29 bp |
Total shareholders' equity / Total assets | 71.5% | 75.3% | -378 bp |
EBIT / P&L interest expense | 72.5 | 56.9 | 27.5% |
Net debt / EBITDA | 0.5 | 0.8 | -31.7% |
Sales (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
---|---|---|---|
Total revenues of Podravka Group | 2,443.8 | 2,238.2 | 9.2% |
Sales revenues of Podravka Group | 2,416.2 | 2,220.5 | 8.8% |
Sales revenues of Food | 1,913.8 | 1,716.6 | 11.5% |
Sales revenues of Pharma | 502.4 | 503.9 | -0.3% |
Podravka Group's profitability (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
Group's gross profit | 881.1 | 843.2 | 4.5% |
Group's gross profit margin | 36.5% | 38.0% | -151 bp |
Group's EBITDA | 365.2 | 356.6 | 2.4% |
Group's EBITDA margin | 15.1% | 16.1% | -94 bp |
Group's EBIT | 252.5 | 248.7 | 1.5% |
Group's EBIT margin | 10.5% | 11.2% | -75 bp |
Group's net profit after MI | 198.2 | 197.6 | 0.3% |
Group's net profit margin after MI | 8.2% | 8.9% | -69 bp |
Podravka Group's balance sheet (in HRKm) | 30.6.2022 | 31.12.2021 | % change |
Total assets | 5,285.3 | 4,909.0 | 7.7% |
Shareholders' equity | 3,732.8 | 3,631.0 | 2.8% |
Minority interests | 68.1 | 63.3 | 7.6% |
Cash and cash equivalents | 219.5 | 33.3 | 559.1% |
Financial debt | 388.1 | 493.8 | -21.4% |
Net debt | 168.6 | 460.5 | -63.4% |
Podravka Group's cash flow (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
Net cash flow from operating activities | 503.0 | 359.7 | 39.8% |
Capital expenditures | (203.8) | (56.5) | 260.3% |
Depreciation and amortization | 107.8 | 112.7 | -4.3% |
Free cash flow | 299.3 | 303.2 | -1.3% |
Podravka Group's ratios and indicators | 30.6.2022 | 31.12.2021 | % change |
Employee number at the end of period (in units) | 6,545 | 6,557 | -0.2% |
P&L interest expense (in HRKm) | 5.8 | 6.8 | -20.9% |
Sales revenues / Number of employees (in HRK000) | 736.9 | 706.3 | 4.3% |
Net profit after MI / Sales revenues (in HRK000) | 47.3 | 47.2 | 0.3% |
Return on average assets | 6.1% | 6.3% | -26 bp |
Return on average capital | 8.3% | 8.8% | -50 bp |
Return on average invested capital | 7.9% | 7.7% | +20 bp |
Total shareholders' equity / Total assets | 71.9% | 75.3% | -334 bp |
EBIT / P&L interest expense | 66.9 | 56.9 | 17.6% |
Net debt / EBITDA | 0.3 | 0.8 | -63.7% |
Sales (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
---|---|---|---|
Total revenues of Podravka Group | 1,177.3 | 1,089.8 | 8.0% |
Sales revenues of Podravka Group | 1,172.6 | 1,079.7 | 8.6% |
Sales revenues of Food | 936.9 | 845.3 | 10.8% |
Sales revenues of Pharma | 235.7 | 234.3 | 0.6% |
Podravka Group's profitability (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
Group's gross profit | 435.6 | 411.8 | 5.8% |
Group's gross profit margin | 37.1% | 38.1% | -100 bp |
Group's EBITDA | 170.3 | 184.5 | -7.7% |
Group's EBITDA margin | 14.5% | 17.1% | -257 bp |
Group's EBIT | 115.2 | 131.1 | -12.2% |
Group's EBIT margin | 9.8% | 12.1% | -232 bp |
Group's net profit after MI | 88.8 | 105.2 | -15.6% |
Group's net profit margin after MI | 7.6% | 9.7% | -217 bp |
Podravka Group's balance sheet (in HRKm) | 31.3.2022 | 31.12.2021 | % change |
Total assets | 5,215.0 | 4,909.0 | 6.2% |
Shareholders' equity | 3,730.0 | 3,631.0 | 2.7% |
Minority interests | 66.5 | 63.3 | 5.1% |
Cash and cash equivalents | 214.8 | 33.3 | 545.0% |
Financial debt | 435.8 | 493.8 | -11.8% |
Net debt | 221.0 | 460.5 | -52.0% |
Podravka Group's cash flow (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
Net cash flow from operating activities | 317.6 | 190.6 | 66.6% |
Capital expenditures | (63.4) | (18.8) | 237.8% |